The New York Stock Exchange announced today that trading has been suspended in the warrants of EQ Health Acquisition, with delisting proceedings set to begin. The exchange cited abnormally low price leveles as the reason.
Trading in the company’s Class A common stock — ticker symbol EQHA — and units — ticker symbol EQHA.U — will continue.
The SPAC has a right to a review of the decision.
EQ Health raised $220 million in a February 2021 IPO with plans to focus on identifying, acquiring and building an undervalued, growth-oriented company in the healthcare services sector. Read more.
